ArticleJACC. Case reports2026
Coronary Vasospasm in Eosinophilic Granulomatosis With Polyangiitis Presenting as Acute Coronary Syndrome Treated With Anti-IL-5.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anesthetic Management of Eosinophilic Granulomatosis with Polyangiitis: A Narrative Review with an Illustrative Case in Cardiac Surgery.Journal of personalized medicine · 2026Review
- Colchicine-Responsive Dacron Hypersensitivity After Bentall Procedure: A Rare Trigger of Diffuse Coronary Artery Disease.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis that may involve the coronary arteries, even in ANCA-negative cases. CASE SUMMARY: A 58-year-old woman with a history of asthma, eosinophilia, and prior percutaneous coronary interventions presented with exertional dyspnea and chest tingling. Electrocardiogram showed transient anterior ST-segment elevations. Coronary angiography revealed multivessel coronary vasospasm with 100% occlusion of the mid left anterior descending artery, reversible with intracoronary nitroglycerin. Laboratory work-up confirmed ANCA-negative EGPA. The patient was initially treated with steroids and vasodilators, then transitioned to benralizumab owing to disease recurrence and steroid dependence. Her symptoms resolved, and eosinophil counts remained suppressed. DISCUSSION: Cardiac involvement in EGPA is uncommon but potentially fatal. This case highlights the importance of considering EGPA in recurrent acute coronary syndrome with eosinophilia and demonstrates the successful use of IL-5-targeted biologic therapy. TAKE-HOME MESSAGES: EGPA should be considered in recurrent acute coronary syndrome with eosinophilia. Benralizumab offers a steroid-sparing strategy in cardiac EGPA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.